PortfoliosLab logo
CPRX vs. MOH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CPRX and MOH is 0.42, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

CPRX vs. MOH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Catalyst Pharmaceuticals, Inc. (CPRX) and Molina Healthcare, Inc. (MOH). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

CPRX:

1.19

MOH:

-0.13

Sortino Ratio

CPRX:

1.95

MOH:

0.09

Omega Ratio

CPRX:

1.22

MOH:

1.01

Calmar Ratio

CPRX:

1.65

MOH:

-0.19

Martin Ratio

CPRX:

6.46

MOH:

-0.54

Ulcer Index

CPRX:

7.40%

MOH:

13.12%

Daily Std Dev

CPRX:

41.35%

MOH:

45.26%

Max Drawdown

CPRX:

-94.25%

MOH:

-68.37%

Current Drawdown

CPRX:

-5.32%

MOH:

-22.45%

Fundamentals

Market Cap

CPRX:

$2.97B

MOH:

$17.63B

EPS

CPRX:

$1.57

MOH:

$21.44

PE Ratio

CPRX:

15.52

MOH:

15.17

PEG Ratio

CPRX:

0.00

MOH:

-0.62

PS Ratio

CPRX:

5.56

MOH:

0.44

PB Ratio

CPRX:

3.65

MOH:

3.95

Total Revenue (TTM)

CPRX:

$534.65M

MOH:

$41.85B

Gross Profit (TTM)

CPRX:

$441.72M

MOH:

$4.78B

EBITDA (TTM)

CPRX:

$250.28M

MOH:

$1.90B

Returns By Period

In the year-to-date period, CPRX achieves a 16.77% return, which is significantly higher than MOH's 11.78% return. Over the past 10 years, CPRX has outperformed MOH with an annualized return of 19.87%, while MOH has yielded a comparatively lower 16.60% annualized return.


CPRX

YTD

16.77%

1M

8.21%

6M

18.30%

1Y

47.79%

5Y*

40.03%

10Y*

19.87%

MOH

YTD

11.78%

1M

0.98%

6M

10.53%

1Y

-6.41%

5Y*

13.41%

10Y*

16.60%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CPRX vs. MOH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CPRX
The Risk-Adjusted Performance Rank of CPRX is 8686
Overall Rank
The Sharpe Ratio Rank of CPRX is 8787
Sharpe Ratio Rank
The Sortino Ratio Rank of CPRX is 8585
Sortino Ratio Rank
The Omega Ratio Rank of CPRX is 8080
Omega Ratio Rank
The Calmar Ratio Rank of CPRX is 9191
Calmar Ratio Rank
The Martin Ratio Rank of CPRX is 9090
Martin Ratio Rank

MOH
The Risk-Adjusted Performance Rank of MOH is 4040
Overall Rank
The Sharpe Ratio Rank of MOH is 4545
Sharpe Ratio Rank
The Sortino Ratio Rank of MOH is 3838
Sortino Ratio Rank
The Omega Ratio Rank of MOH is 3838
Omega Ratio Rank
The Calmar Ratio Rank of MOH is 3838
Calmar Ratio Rank
The Martin Ratio Rank of MOH is 3939
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CPRX vs. MOH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and Molina Healthcare, Inc. (MOH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current CPRX Sharpe Ratio is 1.19, which is higher than the MOH Sharpe Ratio of -0.13. The chart below compares the historical Sharpe Ratios of CPRX and MOH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

CPRX vs. MOH - Dividend Comparison

Neither CPRX nor MOH has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

CPRX vs. MOH - Drawdown Comparison

The maximum CPRX drawdown since its inception was -94.25%, which is greater than MOH's maximum drawdown of -68.37%. Use the drawdown chart below to compare losses from any high point for CPRX and MOH. For additional features, visit the drawdowns tool.


Loading data...

Volatility

CPRX vs. MOH - Volatility Comparison

The current volatility for Catalyst Pharmaceuticals, Inc. (CPRX) is 10.00%, while Molina Healthcare, Inc. (MOH) has a volatility of 15.22%. This indicates that CPRX experiences smaller price fluctuations and is considered to be less risky than MOH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

CPRX vs. MOH - Financials Comparison

This section allows you to compare key financial metrics between Catalyst Pharmaceuticals, Inc. and Molina Healthcare, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B12.00B20212022202320242025
141.42M
11.15B
(CPRX) Total Revenue
(MOH) Total Revenue
Values in USD except per share items

CPRX vs. MOH - Profitability Comparison

The chart below illustrates the profitability comparison between Catalyst Pharmaceuticals, Inc. and Molina Healthcare, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%20212022202320242025
87.3%
11.5%
(CPRX) Gross Margin
(MOH) Gross Margin
CPRX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Catalyst Pharmaceuticals, Inc. reported a gross profit of 123.51M and revenue of 141.42M. Therefore, the gross margin over that period was 87.3%.

MOH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Molina Healthcare, Inc. reported a gross profit of 1.28B and revenue of 11.15B. Therefore, the gross margin over that period was 11.5%.

CPRX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Catalyst Pharmaceuticals, Inc. reported an operating income of 63.37M and revenue of 141.42M, resulting in an operating margin of 44.8%.

MOH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Molina Healthcare, Inc. reported an operating income of 433.00M and revenue of 11.15B, resulting in an operating margin of 3.9%.

CPRX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Catalyst Pharmaceuticals, Inc. reported a net income of 56.74M and revenue of 141.42M, resulting in a net margin of 40.1%.

MOH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Molina Healthcare, Inc. reported a net income of 298.00M and revenue of 11.15B, resulting in a net margin of 2.7%.